Growth Metrics

Gyre Therapeutics (GYRE) Current Leases (2019 - 2026)

Gyre Therapeutics has reported Current Leases over the past 7 years, most recently at $636000.0 for Q4 2025.

  • Quarterly Current Leases fell 10.8% to $636000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $636000.0 through Dec 2025, down 10.8% year-over-year, with the annual reading at $636000.0 for FY2025, 10.8% down from the prior year.
  • Current Leases was $636000.0 for Q4 2025 at Gyre Therapeutics, up from $626000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $2.0 million in Q4 2021 and troughed at $100000.0 in Q1 2024.
  • The 5-year median for Current Leases is $678000.0 (2021), against an average of $916176.5.
  • Year-over-year, Current Leases crashed 79.34% in 2022 and then skyrocketed 705.0% in 2025.
  • A 5-year view of Current Leases shows it stood at $2.0 million in 2021, then tumbled by 75.11% to $492000.0 in 2022, then crashed by 57.32% to $210000.0 in 2023, then surged by 239.52% to $713000.0 in 2024, then dropped by 10.8% to $636000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Current Leases are $636000.0 (Q4 2025), $626000.0 (Q3 2025), and $622000.0 (Q2 2025).